Veterinary Drug Market by Product Category, Route of Administration, Distribution Channel, Animal Type, Disease Indication, Care Setting

The Veterinary Drug Market is projected to reach USD 48.57 Billion in 2026. It is expected to continue growing at a CAGR of 8.70%, reaching USD 80.31 Billion by 2032.

The veterinary drug market is a critical pillar of animal health, food security, companion animal care, and One Health policy. Demand is supported by the medical needs of livestock, poultry, aquaculture, equine, and companion animals, while regulatory oversight from agencies such as the U.S. FDA Center for Veterinary Medicine, USDA APHIS, the European Medicines Agency, and national authorities continues to shape product quality, safety, efficacy, and pharmacovigilance.

Growth in veterinary pharmaceuticals is being driven by the rising burden of infectious and parasitic diseases, higher pet health spending, expanding animal protein consumption, and the need to protect herd productivity. According to WOAH, animal diseases can affect livestock production, trade continuity, and public health, reinforcing the importance of approved veterinary medicines, vaccines, diagnostics-linked treatment, and responsible antimicrobial use. At the same time, the market is shifting toward preventive care, prescription parasiticides, targeted anti-infective stewardship, dermatology therapies, pain management, reproductive health products, and species-specific formulations that align with modern veterinary practice.

Transformative Shifts in the Veterinary Drug Landscape

The veterinary drug landscape is transforming as animal health moves from reactive treatment to prevention, surveillance, and precision care. Regulations such as FDA Guidance for Industry #263, which moved remaining over-the-counter medically important antimicrobials for animals under veterinary oversight in the United States, and Regulation (EU) 2019/6, which strengthened antimicrobial-use controls in Europe, are accelerating responsible prescribing and stewardship.

Manufacturers are also adapting to changes in distribution and care delivery. E-commerce, veterinary clinic networks, telehealth-supported prescribing where permitted, and direct relationships with producers are reshaping access to approved products. Across livestock and companion animal segments, the strongest positioning is shifting toward portfolios that combine clinical efficacy, regulatory compliance, residue management, ease of administration, cold-chain reliability, and measurable outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the veterinary drug value chain, with the highest near-term impact in drug discovery, target identification, clinical trial design, pharmacovigilance, diagnostic decision support, and precision livestock health. AI-enabled models can help screen compounds, analyze real-world evidence, detect adverse event patterns, and connect diagnostic data with treatment protocols, provided that datasets are validated and compliant with applicable data protection, quality management, and veterinary regulations.

In commercial practice, AI is strengthening disease surveillance through herd monitoring, wearable sensors, imaging tools, laboratory data, and production analytics. These capabilities support earlier intervention, better antimicrobial stewardship, improved inventory planning, and more consistent treatment decisions. The cumulative impact is not the replacement of veterinarians, but the creation of evidence-led workflows that help veterinarians, producers, and pet owners use veterinary drugs more responsibly and effectively.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-priority growth region because China, India, Japan, South Korea, Australia, and ASEAN markets combine large livestock populations, expanding pet ownership, and active aquaculture production. FAOSTAT and national agricultural datasets consistently show the region's scale in poultry, swine, dairy, and aquaculture, making disease prevention, vaccines, parasiticides, and anti-infective stewardship central to demand. The region also faces recurring pressure from transboundary animal diseases, which increases the strategic importance of surveillance, biosecurity, veterinary biologics, and regulated access to essential medicines.

North America remains one of the most regulated and innovation-led veterinary drug markets, supported by strong companion animal spending, advanced livestock production, and defined oversight from FDA CVM, USDA APHIS, Health Canada, and state-level veterinary boards. Latin America, led by Brazil and Mexico, is closely tied to beef, poultry, swine, and export-oriented protein supply chains, where residue compliance, disease control, and herd health programs are essential to market access and productivity.

Europe is shaped by rigorous pharmacovigilance, antimicrobial controls, and sustainability requirements under EU and national frameworks, with Regulation (EU) 2019/6 reinforcing prudent use of veterinary medicinal products. The Middle East is expanding demand through food security investments, dairy and poultry modernization, camel and equine health, and companion animal care in urban centers. Africa presents long-term potential linked to livestock disease control, vaccine access, public-sector programs, and the need to reduce productivity losses associated with endemic and transboundary animal diseases, including those prioritized by WOAH and national veterinary services.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are benefiting from poultry, aquaculture, and swine modernization, with demand concentrated in vaccines, parasiticides, biosecurity-linked therapies, and approved anti-infectives. Disease prevention is especially important in dense production systems, while national antimicrobial resistance action plans are increasing attention on veterinary oversight and responsible use. GCC countries are investing in food security, dairy production, camel and equine health, and regulated import pathways, creating opportunities for premium veterinary products, biologics, diagnostics-linked treatment, and cold-chain distribution.

The European Union remains a benchmark for veterinary drug regulation, particularly through Regulation (EU) 2019/6 and coordinated pharmacovigilance, which influence product authorization, antimicrobial stewardship, and post-market monitoring. BRICS markets combine major animal protein production, large companion animal populations, and diverse regulatory maturity, making local registration strategy, quality compliance, and manufacturing partnerships important. G7 markets are characterized by advanced veterinary infrastructure, high compliance expectations, and strong innovation adoption, while NATO countries overlap with many high-income regulated markets where supply resilience, biosecurity, and public health preparedness influence animal health policy and veterinary medicine availability.

Key Country Insights Across Major Veterinary Drug Markets

The United States leads in veterinary drug innovation, regulatory clarity, and companion animal therapeutics, with FDA CVM and USDA APHIS providing distinct oversight for drugs and biologics. Canada has a mature animal health system with strong livestock and companion animal demand, supported by federal veterinary drug review and food safety controls. Mexico links veterinary drug use to poultry, swine, cattle, and cross-border protein trade, where disease management and residue compliance remain central. Brazil is a strategic market because it is one of the world's most important beef and poultry exporters, making disease control, vaccination, parasiticide use, and export-compliant residue management commercially critical.

The United Kingdom, Germany, France, Italy, and Spain combine advanced veterinary services with strict European antimicrobial and pharmacovigilance standards, supporting demand for approved companion animal medicines, livestock vaccines, dermatology products, pain therapies, and preventive health solutions. Russia has substantial livestock production and domestic supply priorities, increasing the importance of local registration, supply continuity, and disease control. China and India are scale markets with significant livestock, aquaculture, and companion animal opportunities, though registration pathways, pricing dynamics, and local competition require careful market entry planning. Japan, Australia, and South Korea are high-compliance markets where premium companion animal therapies, vaccines, parasiticides, biosecurity, and evidence-based prescribing are especially important.

Actionable Recommendations for Veterinary Drug Industry Leaders

Industry leaders should prioritize regulatory-ready portfolios that align with antimicrobial stewardship, residue requirements, pharmacovigilance obligations, and Good Manufacturing Practice expectations. Investment should focus on vaccines, parasiticides, dermatology, pain management, chronic disease therapies, reproductive health, and species-specific formulations where clinical need and owner or producer willingness to pay are clear.

Companies should strengthen local registration expertise, diversify manufacturing and active ingredient sourcing, and build resilient cold-chain and clinic-facing distribution. Partnerships with veterinarians, producer groups, diagnostic providers, universities, and digital health providers can improve adoption, generate real-world evidence, and support differentiated value propositions in both livestock and companion animal segments. Leaders should also embed antimicrobial stewardship metrics, adverse event monitoring, and product education into commercialization to strengthen trust with regulators, veterinarians, producers, and pet owners.

Research Methodology

The research methodology combines secondary research from regulatory agencies, veterinary associations, intergovernmental organizations, scientific literature, trade databases, and public disclosures with structured market interpretation. Key sources include FDA CVM, USDA APHIS, EMA, national veterinary authorities, WOAH, FAO, WHO, Codex Alimentarius guidance, antimicrobial resistance action plans, and peer-reviewed animal health research.

Market assessment is developed through triangulation of regulatory developments, disease burden indicators, animal population trends, livestock production patterns, companion animal care dynamics, product approvals, distribution shifts, and expert-led validation. This approach supports data-backed insights without relying on unverified assumptions, unsupported market claims, market sizing, market share statements, or forecasting.

Conclusion

The veterinary drug market is becoming more prevention-driven, regulated, digitally enabled, and outcome-focused. Companies that combine scientific credibility, responsible antimicrobial practices, reliable supply, strong pharmacovigilance, and region-specific commercialization strategies are best positioned to capture growth.

As animal health becomes more closely linked to food security, public health, trade continuity, and sustainability, veterinary drug manufacturers must deliver products that meet clinical, regulatory, and economic expectations. The strongest opportunities will favor organizations that convert evidence, compliance, and innovation into trusted therapeutic value for veterinarians, producers, and pet owners.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Drug Market, by Product Category

7.1. Anti-Infectives
7.1.1. Antibiotics
7.1.2. Antifungals
7.1.3. Antivirals
7.2. Anti-Inflammatories
7.3. Parasiticides
7.3.1. Ectoparasiticides
7.3.2. Endoparasiticides
7.3.3. Endectocides
7.4. Vaccines
7.4.1. Core Vaccines
7.4.2. Non-Core Vaccines
7.4.3. Autogenous Vaccines
7.5. Anti-Inflammatory & Pain Management
7.5.1. NSAIDs
7.5.2. Corticosteroids
7.5.3. Analgesics
7.6. Hormones & Reproductive Health
7.7. Dermatology
7.8. Gastrointestinal
7.8.1. Antiemetics
7.8.2. Antidiarrheals

8. Veterinary Drug Market, by Route Of Administration

8.1. Inhalation
8.2. Parenteral
8.2.1. Intramuscular
8.2.2. Subcutaneous
8.2.3. Intravenous
8.2.4. Intradermal
8.3. Oral
8.3.1. Tablets & Capsules
8.3.2. Oral Liquids
8.3.3. Chewables
8.3.4. Medicated Feed & Water
8.4. Topical
8.4.1. Creams & Ointments
8.4.2. Sprays
8.5. Ophthalmic

9. Veterinary Drug Market, by Distribution Channel

9.1. Online Pharmacies
9.2. Retail Pharmacies
9.3. Veterinary Hospitals
9.4. Feed & Farm Supply Stores
9.5. Government & Institutional Procurement

10. Veterinary Drug Market, by Animal Type

10.1. Companion Animals
10.1.1. Dogs
10.1.2. Cats
10.1.3. Small Mammals
10.1.3.1. Rabbits
10.1.3.2. Guinea Pigs
10.1.3.3. Ferrets
10.1.4. Birds
10.1.4.1. Psittacines
10.1.4.2. Passerines
10.1.5. Exotics
10.1.5.1. Reptiles
10.1.5.2. Amphibians
10.2. Livestock Animals
10.2.1. Cattle
10.2.1.1. Dairy Cattle
10.2.1.2. Beef Cattle
10.2.2. Swine
10.2.2.1. Breeding Swine
10.2.2.2. Finisher Swine
10.2.3. Poultry
10.2.3.1. Broilers
10.2.3.2. Layers
10.2.4. Small Ruminants
10.2.4.1. Sheep
10.2.4.2. Goats
10.2.5. Aquaculture
10.2.5.1. Freshwater
10.2.5.2. Marine
10.3. Equines
10.3.1. Horses
10.3.2. Donkeys & Mules
10.4. Laboratory Animals
10.5. Zoo & Wildlife Animals

11. Veterinary Drug Market, by Disease Indication

11.1. Infectious Diseases
11.2. Dermatological Disorders
11.3. Respiratory Disorders
11.4. Gastrointestinal Disorders
11.5. Musculoskeletal Disorders
11.6. Reproductive Disorders
11.7. Neurological Disorders
11.8. Ophthalmic Disorders

12. Veterinary Drug Market, by Care Setting

12.1. Companion Animal Practice
12.2. Livestock Production Operations
12.3. Aquaculture Farms
12.4. Research Institutions
12.5. Shelters & Rescue Organizations
12.6. Zoos & Wildlife Centers

13. Asia-Pacific Veterinary Drug Market
14. Europe Veterinary Drug Market
15. North America Veterinary Drug Market
16. Latin America Veterinary Drug Market
17. Africa Veterinary Drug Market
18. Middle East Veterinary Drug Market
19. NATO Veterinary Drug Market
20. G7 Veterinary Drug Market
21. European Union Veterinary Drug Market
22. BRICS Veterinary Drug Market
23. ASEAN Veterinary Drug Market
24. GCC Veterinary Drug Market
25. United States Veterinary Drug Market
26. China Veterinary Drug Market
27. Germany Veterinary Drug Market
28. Japan Veterinary Drug Market
29. India Veterinary Drug Market
30. United Kingdom Veterinary Drug Market
31. France Veterinary Drug Market
32. Canada Veterinary Drug Market
33. Italy Veterinary Drug Market
34. Australia Veterinary Drug Market
35. South Korea Veterinary Drug Market
36. Brazil Veterinary Drug Market
37. Mexico Veterinary Drug Market
38. Russia Veterinary Drug Market
39. Spain Veterinary Drug Market

40. Competitive Landscape

40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025

41. Company Profiles

41.1. Zoetis Inc.
41.2. Merck & Co., Inc.
41.3. Boehringer Ingelheim International GmbH
41.4. Elanco Animal Health Incorporated
41.5. Ceva Santé Animale
41.6. Virbac S.A.
41.7. Dechra Pharmaceuticals PLC
41.8. Phibro Animal Health Corporation
41.9. Norbrook Group
41.10. Vetoquinol Group
41.11. Neogen Corporation
41.12. Chanelle Pharma
41.13. Aurora Pharmaceutical, Inc.
41.14. Biogénesis Bagó S.A.
41.15. Biovac Ltd.
41.16. China Animal Husbandry Industry Co., Ltd.
41.17. ECO Animal Health Group PLC
41.18. Heska Corporation by Mars, Incorporated
41.19. Hester Biosciences Limited
41.20. Indian Immunologicals Ltd.
41.21. Intas Pharmaceuticals Ltd.
41.22. Laboratorio Drag Pharma Chile Invetec S.A.
41.23. Teknofarma S.r.l.
41.24. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
41.25. Zendal Group

List of Figures

FIGURE 1. GLOBAL VETERINARY DRUG MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY DRUG MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY DRUG MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY DRUG MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
FIGURE 25. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CHINA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. JAPAN VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. INDIA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. CANADA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. AUSTRALIA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. BRAZIL VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. MEXICO VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. RUSSIA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL VETERINARY DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VETERINARY DRUG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIFUNGALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIFUNGALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIFUNGALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIVIRALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIVIRALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIVIRALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ENDECTOCIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ENDECTOCIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ENDECTOCIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CORE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CORE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CORE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NON-CORE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NON-CORE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NON-CORE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANALGESICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GASTROINTESTINAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GASTROINTESTINAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GASTROINTESTINAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANTIEMETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANTIEMETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANTIEMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL INHALATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL INTRADERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL INTRADERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL INTRADERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ORAL LIQUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ORAL LIQUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ORAL LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CHEWABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CHEWABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CHEWABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL SMALL MAMMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL SMALL MAMMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL SMALL MAMMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL RABBITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL RABBITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL RABBITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL GUINEA PIGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL GUINEA PIGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL GUINEA PIGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL FERRETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL FERRETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL FERRETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BIRDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL PSITTACINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL PSITTACINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL PSITTACINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL PASSERINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL PASSERINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL PASSERINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL EXOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL EXOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL EXOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL REPTILES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL REPTILES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL REPTILES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL AMPHIBIANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL AMPHIBIANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL AMPHIBIANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL DAIRY CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL DAIRY CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL DAIRY CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BEEF CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL BEEF CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BEEF CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BREEDING SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL BREEDING SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BREEDING SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL FINISHER SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL FINISHER SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL FINISHER SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL BROILERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL BROILERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL BROILERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL LAYERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL LAYERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL LAYERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL SMALL RUMINANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL SMALL RUMINANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL SMALL RUMINANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL FRESHWATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL FRESHWATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL FRESHWATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL MARINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL MARINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL MARINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL EQUINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL EQUINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL EQUINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL DONKEYS & MULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL DONKEYS & MULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL DONKEYS & MULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 260. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 264. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
TABLE 266. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 268. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 271. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 274. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 277. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 278. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 280. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 281. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 283. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 284. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 285. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 286. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 287. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 288. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
TABLE 306. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 307. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
TABLE 308. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 309. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
TABLE 310. EUROPE VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 311. EUROPE VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 312. EUROPE VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 313. EUROPE VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 314. EUROPE VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 315. EUROPE VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 316. EUROPE VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 317. EUROPE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 318. EUROPE VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 319. EUROPE VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 320. EUROPE VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 321. EUROPE VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 322. EUROPE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 323. EUROPE VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 324. EUROPE VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 325. EUROPE VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
TABLE 326. EUROPE VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
TABLE 327. EUROPE VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 328. EUROPE VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 329. EUROPE VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
TABLE 330. EUROPE VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 331. EUROPE VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
TABLE 332. EUROPE VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 333. EUROPE VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
TABLE 334. EUROPE VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 335. EUROPE VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
TABLE 336. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 337. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 338. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 339. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 340. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 341. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 342. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 343. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 344. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 345. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 346. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 347. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 348. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 349. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 350. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 351. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
TABLE 352. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
TABLE 353. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 354. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 355. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
TABLE 356. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 357. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
TABLE 358. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 359. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
TABLE 360. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 361. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
TABLE 362. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 363. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 364. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
TABLE 365. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
TABLE 366. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 367. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 368. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 369. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 370. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 371. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 372. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 373. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 374. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 375. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 376. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
TABLE 377. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
TABLE 378. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
TABLE 379. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 380. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
TABLE 381. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
TABLE 382. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
TABLE 383. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
TABLE 384. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
TABLE 385. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
TABLE 386. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 387. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
TABLE 388. AFRICA VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 389. AFRICA VETERINARY DRUG MARKET SIZE

Companies Mentioned

The companies featured in this Veterinary Drug market report include:

Zoetis Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health Incorporated
Ceva Santé Animale
Virbac S.A.
Dechra Pharmaceuticals PLC
Phibro Animal Health Corporation
Norbrook Group
Vetoquinol Group
Neogen Corporation
Chanelle Pharma
Aurora Pharmaceutical, Inc.
Biogénesis Bagó S.A.
Biovac Ltd.
China Animal Husbandry Industry Co., Ltd.
ECO Animal Health Group PLC
Heska Corporation by Mars, Incorporated
Hester Biosciences Limited
Indian Immunologicals Ltd.
Intas Pharmaceuticals Ltd.
Laboratorio Drag Pharma Chile Invetec S.A.
Teknofarma S.r.l.
Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
Zendal Group

Table Information

Report Attribute	Details
No. of Pages	189
Published	June 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 48.57 Billion
Forecasted Market Value ( USD ) by 2032	$ 80.31 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3211EUR$3,545USD£2,770GBP €3568EUR$3,939USD£3,078GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4858EUR$5,363USD£4,191GBP €5398EUR$5,959USD£4,657GBP

Veterinary Drug Market by Product Category, Route of Administration, Distribution Channel, Animal Type, Disease Indication, Care Setting - Global Forecast 2026-2032

Transformative Shifts in the Veterinary Drug Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Key Country Insights Across Major Veterinary Drug Markets

Actionable Recommendations for Veterinary Drug Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Transformative Shifts in the Veterinary Drug Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Key Country Insights Across Major Veterinary Drug Markets

Actionable Recommendations for Veterinary Drug Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Veterinary Therapeutics Market by Product Type, Animal Type, Route of Administration, Disease Type, End User, Distribution Channel - Global Forecast 2026-2032

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 3, 2026)

Veterinary Pharmaceuticals Market by Product Type, Route of Administration, Animal Type, Indications, Distribution Channel, End User - Global Forecast 2026-2032